<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-96170</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Synthesis of Selective MMP-2 Inhibitors Using Click Chemistry</dc:title>
<dc:description xml:lang="en">A new series of selective MMP-2 inhibitors is described, following a fragment-based drug design approach. A fragment containing an azide group and a well known hydroxamate ZBG, was synthesized. A click chemistry reaction was used to connect the azide to lipophilic alkynes selected to interact selectively with the S1&#146; subunit of MMP-2. The most active compounds, 20 and 21, displayed high values of IC50 against MMP-2. In addition, compound 20 has shown also a promissing selectivity profile against some antitarget metalloproteinases in cancer, such as MMP-8, and MMP-9(AU)</dc:description>
<dc:creator>Martínez, Alfredo</dc:creator>
<dc:creator>Zapico, José María</dc:creator>
<dc:creator>Pascual-Teresa, Beatriz de</dc:creator>
<dc:creator>Serra, Pilar</dc:creator>
<dc:creator>Filipiak, Kamila</dc:creator>
<dc:creator>Martín Santamaría, Sonsoles</dc:creator>
<dc:creator>García Sanmartín, Josune</dc:creator>
<dc:creator>Ramos, Ana</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Siguiendo una estrategia de diseño basado en fragmentos, se describe la síntesis de una nueva serie de inhibidores de MMP-2. Para ello, se parte de un fragmento que contiene simultáneamente un grupo hidroxamato como Zinc Binding Group (ZBG) y un grupo azida. Esta subunidad se conecta mediante química &#147;click" con otros fragmentos lipófilos que contienen un alquino terminal y que han sido seleccionados para interaccionar de manera selectiva con el subsitio S1&#146; de la MMP-2. Los compuestos sintetizados más activos, 20 y 21, presentan una alta potencia inhibitoria en MMP-2. Además, el compuesto 20 presenta un prometedor perfil de selectividad frente a algunas metaloproteasas consideradas anti-diana en cáncer, como MMP-8 y MMP-9(AU)</dc:description>
<dc:source>An Real Acad Farm;77(4): 99-117, oct.-dic. 2011. tab, ilus</dc:source>
<dc:identifier>ibc-96170</dc:identifier>
<dc:title xml:lang="es">Síntesis de Inhibidores Selectivos de MMP-2 utilizando Química Click</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d4403^s22045</dc:subject>
<dc:subject>^d34441^s22006</dc:subject>
<dc:subject>^d33425^s29165</dc:subject>
<dc:subject>^d23621</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d974^s29165</dc:subject>
<dc:type>article</dc:type>
<dc:date>201112</dc:date>
</metadata>
</record>
</ibecs-document>
